US2014206631A1PendingUtilityA1
Cardiac Glycoside Analogs in Combination with Emodin for Cancer Therapy
Est. expiryNov 13, 2030(~4.3 yrs left)· nominal 20-yr term from priority
Inventors:Nadav Shraibom
A61P 43/00A61K 31/7048A61K 36/72A61K 36/708A61P 35/02A61K 36/704A61P 35/00A61K 45/06A61K 31/122
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method and medicine for treating leukemia or other cancer includes administering to a patient diagnosed with leukemia or other cancer a treatment regimen that includes periodic doses of a combination of emodin and digoxin.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of preparing medicine for treating leukemia, melanoma, or colon, prostate or breast cancer, comprising preparing a combination including an effective amount of digoxin with 5 ug/ml or more of emodin.
2 . The method of claim 1 , wherein the combination comprises approximately 10 g/ml or more of emodin.
3 . The method of claim 1 , wherein the combination comprises approximately 0.05 ug/ml or more of digoxin.
4 . The method of claim 1 , wherein the combination comprises approximately 0.10 ug/ml or more of digoxin.
5 . The method of claim 1 , wherein the combination comprises approximately 10 ug/ml or more of emodin and approximately 0.10 ug/ml or more of digoxin.
6 . The method of claim 1 , wherein the combination comprises approximately 10 ug/ml or more of emodin and approximately 0.05 ug/ml or more of digoxin.
7 . The method of claim 1 , comprising preparing an aqueous solution including cooking emodin- and digoxin-containing herbs in water.
8 . The method of claim 1 , comprising extracting the emodin from rhubarb root.
9 . The method of claim 1 , comprising extracting the emodin from rhubarb.
10 . The method of claim 1 , comprising extracting the emodin from Buckthorn.
11 . The method of claim 1 , comprising extracting the emodin from Japanese Knotweed.
12 . A medicine for treating leukemia, melanoma, or colon, prostate or breast cancer, comprising a combination of an effective amount of digoxin with approximately 5 ug/ml or more of emodin.
13 . The medicine of claim 12 , comprising approximately 10 g/ml or more of emodin.
14 . The medicine of claim 12 , comprising approximately 0.05 ug/ml or more of digoxin.
15 . The medicine of claim 12 , comprising approximately 0.1 ug/ml or more of digoxin.
16 . The medicine of claim 12 , comprising approximately 10 ug/ml or more of emodin and approximately 0.10 ug/ml or more of digoxin.
17 . The medicine of claim 12 , comprising approximately 10 g/ml or more of emodin and approximately 0.05 ug/ml or more of digoxin.
18 . The medicine of claim 12 , comprising a pharmaceutically acceptable carrier.
19 . The medicine of claim 18 , wherein the carrier comprises water.
20 . The medicine of claim 18 , wherein the carrier comprises DMSO.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.